CN Patent

CN105294690B — 制备包括反-7-氧代-6-(磺基氧基)-1,6-二氮杂二环[3,2,1]辛烷-2-甲酰胺的杂环化合物及其盐的方法

Assigned to Ashley Connan Tellier first Ltd. · Expires 2018-07-10 · 8y expired

What this patent protects

本发明涉及化合物和制备式(I)化合物的方法，所述式(I)化合物包括例如反‑7‑氧代‑6‑(磺基氧基)‑1,6‑二氮杂二环[3,2,1]辛烷‑2‑甲酰胺的化合物及其盐(例如NXL‑104)。 (I)。

USPTO Abstract

本发明涉及化合物和制备式(I)化合物的方法，所述式(I)化合物包括例如反‑7‑氧代‑6‑(磺基氧基)‑1,6‑二氮杂二环[3,2,1]辛烷‑2‑甲酰胺的化合物及其盐(例如NXL‑104)。 (I)。

Drugs covered by this patent

Patent Metadata

Patent number: CN105294690B
Jurisdiction: CN
Classification: —
Expires: 2018-07-10
Drug substance claim: No
Drug product claim: No
Assignee: Ashley Connan Tellier first Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.